Between November 20 and 22, 2019, the CEX-IMAG project implementation team paid a Cluster to Cluster visit at the Lyon headquarters of the Canceropole Lyon Auvergne Rhone-Alpes Cluster.
During the mission, presentations of the activities and research themes of the two clusters were made, common projects were identified that can be developed by the two clusters within the forth coming or on going calls at European level, possibilities for cooperation through study mobilities between universities and member research centers. Researchers from the University of Grenoble presented projects in the field of brain tumor research, respectively fundamental research in the field of radiopharmaceuticals.
As main research topics in collaboration were discussed the conduct of retro-prospective studies on the identification, quantification of radiation, nanoparticles of contamination from external and / or professional environment in the genesis and evolution of glioblastomas, as well as collaborations in the field of animal models development, respectively. radiopharmaceuticals. The Leon Berard Center (Centers for Cancer Fighting) was visited, and within it the Laboratory of Constitutional Genetics, the CERMEP Imagerie du Vivant Center, an integrated imaging platform that has been available for 20 years at universities and hospitals in Lyon in the purpose of imaging research.
The canceropole cluster Lyon Auvergne Rhone-Alpes has been active in the region since 2003, based on the French National Cancer Program. CLARA is a facilitator of the network of actors in the field of oncology in the Auvergne Rhone Alpes region, aggregating between 2003 and 2018 a total of 3,300 researchers in cancerology, 3,500 medical professionals dedicated to oncology, 75 active companies in the field, 210 academic teams and clinical, 216 research projects supported.
The activity was carried out within the project “Increasing the excellence of the IMAGO-MOL Cluster by developing the strategic planning documents CDI (CEX – IMAG)”, carried out by the IMAGO-MOL Cluster and funded by UEFISCDI through PNCDI III.